Clinical trial
Effects of Fenofibrate 160mg to 54mg Conversion on Triglyceride Levels in Patients on Statin Therapy
NCT01280604 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Fenofibrate 160mg to 54mg Conversion on Triglyceride Levels in Patients on Statin Therapy
- Lead sponsor
- Kaiser Permanente
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2010
- Completion date
- January 31, 2013
- Enrollment
- 66 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.